OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
October 05, 2023
Clene was awarded the four-year grant for the National Institute of Neurological Disorders and Stroke to support an Expanded Access Protocol for ALS drug.
September 26, 2023
The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.
September 25, 2023
VistaPharm is recalling Sucralfate Oral Suspension, 1g/10mL because of Bacillus cereus contamination.
September 19, 2023
The agency’s work with EUnetHTA 21 helped it to prepare the EU for implementation of the regulation.
September 18, 2023
The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
September 03, 2023
Excipients should be treated equally when it comes to quality management, risk assessment, and testing.